Comment
. 2007 Jun;5(2):174-5; author reply 175-6.
doi: 10.1016/j.amjopharm.2007.06.002.
Rasagiline as a therapy for Parkinson's disease (PD)
- PMID: 17719520
- DOI: 10.1016/j.amjopharm.2007.06.002
Item in Clipboard
Comment
Rasagiline as a therapy for Parkinson's disease (PD)
Am J Geriatr Pharmacother.
2007 Jun.
No abstract available
Comment on
-
Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46. doi: 10.1016/j.amjopharm.2006.12.001. Am J Geriatr Pharmacother. 2006. PMID: 17296539 Review.
Similar articles
-
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.Clin Ther. 2007 Sep;29(9):1825-49. doi: 10.1016/j.clinthera.2007.09.021. Clin Ther. 2007. PMID: 18035186 Review.
-
Rasagiline in Parkinson's disease.Int Rev Neurobiol. 2011;100:151-68. doi: 10.1016/B978-0-12-386467-3.00008-X. Int Rev Neurobiol. 2011. PMID: 21971007 Review.
-
New drug treatment for Parkinson's disease.FDA Consum. 2006 Jul-Aug;40(4):7. FDA Consum. 2006. PMID: 17245831 No abstract available.
-
Rasagiline. Parkinson's disease: a simple me-too.Prescrire Int. 2006 Dec;15(86):220. Prescrire Int. 2006. PMID: 17167927
-
Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.Am J Geriatr Pharmacother. 2006 Dec;4(4):330-46. doi: 10.1016/j.amjopharm.2006.12.001. Am J Geriatr Pharmacother. 2006. PMID: 17296539 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
